Trial Profile
Open-label Comparative Randomized Study of the Efficacy and Safety of Orlistat (Xenical) in Complex Therapy of Obesity and Metabolic Disorders in Adolescents.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Dec 2016
Price :
$35
*
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Registrational; Therapeutic Use
- 05 Sep 2013 Treatment table added.
- 15 Jun 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
- 15 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.